BRAINBox Solutions
PrivateLast Round
Series B
Oct 30, 2023
Total Funding Raised
$27M
Company Overview
BRAINBox Solutions operates in Healthcare & Life Sciences and is based in Richmond, Virginia. Its latest recorded funding round was a VC Round in May 2023.
BRAINBox Solutions is a healthcare technology company that provides a comprehensive platform for the diagnosis and prognosis of mild traumatic brain injury through blood biomarker panels, standard laboratory systems, and neurocognitive testing.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Biotechnology, Clinical Trials, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BRAINBox Solutions Comparables
Compare BRAINBox Solutions with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoDx | 86% | |
| BrainScope | 81% | |
| Marker AG | 80% |
For institutional investors. Book with your work email.
BRAINBox Solutions Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 30, 2023 | ||||
| VC Round | May 1, 2023 | ||||
| Grant | Mar 21, 2022 | ||||
| Series A | Dec 8, 2020 | ||||
| Grant | May 30, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BRAINBox Solutions Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Astia Angels | Series A |
| Genoa Ventures | Series A, Series B |
| BioVentures Investors | Series A |
| Virginia Venture Partners | VC Round |
| Pharmakon Advisors | Series A |
| National Institute of Neurological Disorders and Stroke | Grant |
| Laszlo N. Tauber Family Foundation | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
Provided update on TBI diagnostic/prognostic test program progress.
- Apr 23, 2025
Integrated diagnostic technologies with Oragenics' therapeutic candidate ONP-002.
For institutional investors. Book with your work email.
BRAINBox Solutions Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BRAINBox Solutions's valuation, stock price, and market status.
Is BRAINBox Solutions a public or private company?
BRAINBox Solutions is a private company.
What is the current stock price of BRAINBox Solutions?
BRAINBox Solutions is a private company, so its shares have no public market price. Caplight tracks BRAINBox Solutions's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BRAINBox Solutions worth (valuation)?
Valuation information for BRAINBox Solutions is not publicly available.
Can I buy BRAINBox Solutions stock?
BRAINBox Solutions shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BRAINBox Solutions's last funding round?
BRAINBox Solutions's most recent funding round was Series B on October 30, 2023.
Who are the main investors in BRAINBox Solutions?
Key investors in BRAINBox Solutions include Genoa Ventures, BioVentures Investors.
Will BRAINBox Solutions IPO soon?
No public IPO plans have been announced for BRAINBox Solutions.
How can I track BRAINBox Solutions secondary market activity?
Caplight tracks bids, offers, and trades in BRAINBox Solutions's shares on secondary markets.